A multicenter evaluation of a new quantitative highly sensitive D-dimer assay for exclusion of venous thromboembolism

Summary

D-dimer testing is widely applied for exclusion of deep-vein thrombosis (DVT) and pulmonary embolism (PE).We report on a multicenter performance evaluation of a new particle-enhanced immuno assay Innovance™ D-Dimer. Innovance D-Dimer assay was performed in 1,543 frozen samples from outpatients suspected of DVT and/or PE enrolled in three management studies as well as in a routine clinical practice. Samples were assayed on BCS®/BCS® XP, BCT® as well as Sysmex® CA-7000, CA-1500 and CA-560 analyzers (cut-off on all analyzers: 0.5 mg/l). Stratus® CS D-Dimer and Vidas® D-Dimer Exclusion were used for comparison. The precision study indicated total coefficients of variation ranging from 2.1% to 8.4% depending on the analyzer and on the sample. Sensitivity and negative predictive values were above 99% and their lower 95% confidence interval were equal or above 97.4% and 98.6%, respectively. Specificity ranged from 38.2% to 40.4% and the respective lower 95% confidence intervals from 35.5% to 37.7%. Area under the curve was 0.90 for all assay systems except for Innovance D-Dimer with BCT (0.89).Two samples from patients with distal DVT tested negative with all assay systems. One patient with high pre-test clinical probability and proximal DVT tested negative with Vidas D-Dimer Exclusion. Our data indicate that the performances of Innovance D-Dimer, regardless of the analyzer, are similar to the reference methods, and that this assay can be used for the exclusion of venous thromboembolic disease.

Keywords

D-dimer - deep venous thrombosis - pulmonary embolism

• References

• 1 Wells PS. Integrated strategies for the diagnosis of venous thromboembolism. J Thromb Haemost 2007; 05 (Suppl. 01) 41-50.
• 2 Gibson NS, Sohne M, Kruip MJ. et al. and the Christopher study investigators. Further validation and simplification of the Wells clinical decision rule in pulmonary embolism. Thromb Haemost 2008; 99: 229-234.
• 3 Klok FA, Kruisman E, Spaan J. et al. Comparison of the revised Geneva score with the We lls rule for assessing clinical probability of pulmonary embolism. J Thromb Haemost 2008; 06: 40-44.
• 4 Nijkeuter M, Kwakkel-van Erp H, Söhne M. et al. and the Christopher Study Investigators. Clinically suspected acute recurrent pulmonary embolism: a diagnostic challenge. Thromb Haemost 2007; 97: 944-948.
• 5 Goekoop RJ, Steeghs N, Niessen RW. et al. Simple and safe exclusion of pulmonary embolism in outpatients using quantitative D-dimer and Wells' simplified decision rule. Thromb Haemost 2007; 97: 146-150.
• 6 Dempfle CE, Zips S, Ergul H. et al. The fibrin assay comparison trial (FACT): evaluation of 23 quantitative D-dimer assays as basis for the development of D-dimer calibrators. FACT study group. Thromb Haemost 2001; 85: 671-678.
• 7 Brown MD, Rowe BH, Reeves MJ. et al. The accuracy of the enzyme-linked immunosorbent assay D-dimer test in the diagnosis of pulmonary embolism: A meta-analysis. Ann Emerg Med 2002; 40: 133-144.
• 8 Kelly J, Rudd A, Lewis R. et al. Plasma D-dimers in the diagnosis of venous thromboembolism. Arch Intern Med 2002; 1162: 747-756.
• 9 Brown MD, Lau J, Nelson RD. et al. Turbidimetric D-dimer test in the diagnosis of pulmonary embolism: A meta-analysis. Clin Chem 2003; 49: 1846-1853.
• 10 Stein PD, Hull RD, Patel KC. et al. D-dimer for the exclusion of acute venous thrombosis and pulmonary embolism. A systematic review. Ann Intern Med 2004; 140: 589-602.
• 11 Di Nisio M, Squizzato A, Rutjes AW. et al. Diagnostic accuracy of D-dimer test for exclusion of venous thromboembolism: a systematic review. J Thromb Haemost 2007; 05: 296-304.
• 12 Jennings I, Woods TA, Kitchen DP. et al. Laboratory D-dimer measurement: improved agreement between methods through calibration. Thromb Haemost 2007; 98: 1127-1135.
• 13 Wells PS, Anderson DR, Bormanis J. et al. Value of assessment of pretest probability of deep-vein thrombosis in clinical management. Lancet 1997; 350: 1795-1798.
• 14 Perrier A, Roy PM, Aujesky D. et al. Diagnosing pulmonary embolism in outpatients with clinical assessment, D-dimer measurement, venous ultrasound, and helical computed tomography: a multicenter management study. Am J Med 2004; 116: 291-299.
• 15 Aguilar C, del Villar V. Combined D-dimer and clinical probability are useful for exclusión of recurrent deep venous trombosis. Am J Hematol 2007; 82: 41-44.
• 16 Pittet JL, de Moerloose P, Reber G. et al. VIDAS D-dimer: fast quantitative ELISA for measuring D-dimer in plasma. Clin Chem 1996; 42: 410-415.
• 17 Reber G, Bounameaux H, Perrier A. et al. A new rapid point-of-care D-dimer enzyme-linked immunosorbent assay (Stratus CSD-dimer) for the exclusion of venous thromboembolism. Blood Coagul Fibrinolysis 2004; 15: 435-438.
• 18 Ten Cate-Hoek AJ, Prins MH. Management studies using a combination of D-dimer test result and clinical probability to rule out venous thromboembolism: a systematic review. J Thromb Haemost 2005; 03: 2465-2470.
• 19 Arnason T, Wells PS, Forster AJ. Appropriateness of diagnostic strategies for evaluating suspected venous thromboembolism. Thromb Haemost 2007; 97: 195-201.
• 20 Reber G, de Moerloose P. D-dimer assays for the exclusion of venous thromboembolism. Sem Thromb Hemost 2000; 26: 619-624.
• 21 Jennersjö CM, Fagerberg IH, Karlander SG. et al. Normal D-dimer concentration is a common finding in symptomatic outpatients with distal deep vein thrombosis. Blood Coagul Fibrinolysis 2005; 16: 517-523.
• 22 Levinson SS, Miller JJ. Towards a better understanding of heterophile (and the like) antibody interference with modern immunoassays. Clin Chim Acta 2002; 5325: 1-15.
• 23 Woodhams B, Girardot O, Blanco MJ. et al. Stability of coagulation proteins in frozen plasma. Blood Coagul Fibrinolysis 2001; 12: 229-236.
• 24 Lewis MR, Callas PW, Jenny NS. et al. Longitudinal stability of coagulation, fibrinolysis, and inflammation factors in stored plasma samples. Thromb Haemost 2001; 86: 1495-1500.